eoadjuvant Chemotherapy for HER2-positive Stage IV advanced gastric cancer with S-1/Cisplatin/Trastuzumab
Phase 1
Recruiting
- Conditions
- Gastric Cancer
- Registration Number
- JPRN-UMIN000005548
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1. Malignant tumor of other organs 2. Severe medical condition 3. Active bleeding from gastrointestinal tract 4. Poor oral intake 5. Contraindication for S-1, Cisplatin or Trastuzumab
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method